|
Market Cap (5-Jun) $15,814,746 (1,167th) |
Close (30-Jun) $0.065 |
Volume (30-Jun) 262,908 |
Shortsold (21-May) 449,649 (0.11%) (451st) |
|
52w High $0.110 |
52w Low $0.034 |
P/E 4.63 |
EPS -0.01 |
IDT released this announcement to the ASX on 13 December 2021, 11:03. The announcement is not marked as price sensitive, and is 12 page(s) in length and 1.36MB in size.
You can view all announcements from IDT and see how they appear on a price chart on the announcements page.
At the date of this announcement, IDT was 0.036% short sold according to ASIC data. It was ranked the 536th most shorted stock on the ASX. It is now ranked as the 451st most shorted stock on the ASX with 0.105% of total shares short sold as of the latest reported data (21 May 2026).
| Other Recent Announcements from IDT | |
|---|---|
| Proposed issue of securities - IDT | 30 June 2023, 9:47 |
| Notice of General Meeting/Proxy Form | 30 June 2023, 9:36 |
| Notification of cessation of securities - IDT | 29 June 2023, 14:55 |
| IDT Australia Limited Investor Update - mRNA | 13 December 2021, 11:03 |
| Ceasing to be a substantial holder | 7 December 2021, 18:10 |
| Becoming a substantial holder | 3 December 2021, 12:23 |
| Australia's 1st mRNA COVID-19 Vaccine Candidate Manufacture | 30 November 2021, 11:45 |
You must be logged in to post a reply.
IDT Australia 